BU-NOT-SET

CONTACT US
Plasmid DNA manufacturing capabilities
  • Biologics
plasmid DNA manufacturing
Fact sheet
Leveraging analytics throughout development and manufacture to achieve commercial success
  • Analytical chemistry
  • Drug substance
development
Insight
2,300 solar panels installed at Recipharm’s Holmes Chapel
  • Sustainability
solar panels
Insight
Analysing prebiotic oligosaccharides for future product innovation
  • Analytical chemistry
  • Drug substance
Workers
White paper
Enhancing sterile processing for future vaccine programs
  • Industry trends
  • Manufacturing
Manufacturing
Insight
Increasing carbon emission transparency through SBTi contributions
  • Sustainability
SBTi
Insight
Single-use technologies are enabling increasing demand for biologics
  • Biologics
People
Insight
Overcoming the challenges surrounding manufacturing oncolytic viruses
  • Biologics
Virus
Insight
Insights from DCAT Week: Exploring drug storage, drug dosage and the supply chain
  • Drug product
  • Industry trends
DCAT insights
Insight
Insight
  • Drug substance
The oncolytic efficacy and in vivo pharmacokinetics of [2-(4- Chlorophenyl)quinolin-4-yl](piperidine-2-yl)methanol (Vacquinol-1) are governed by distinct stereochemical features
Insight
  • Manufacturing
Strategies to prepare for serialisation
Insight
  • Drug substance
A Versatile One-Pot Procedure for the Synthesis of 5-Aryl-6H- 1,3,4-thiadiazine-2-amines from Aromatic Ketones